Shiliang Liu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Placebo Controlled

Squamous Cell Carcinoma

Top Venues

British journal of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Baoqing Chen, Shiliang Liu, Yujia Zhu, Ruixi Wang, Xingyuan Cheng, Biqi Chen, Mihnea P Dragomir, Yaru Zhang, Yonghong Hu, Mengzhong Liu, Qiaoqiao Li, Hong Yang, Mian Xi
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab. Nature communications 15 (1) (2024)
Baoqing Chen, Shiliang Liu, Yujia Zhu, Ruixi Wang, Xingyuan Cheng, Biqi Chen, Mihnea P Dragomir, Yaru Zhang, Yonghong Hu, Mengzhong Liu, Qiaoqiao Li, Hong Yang, Mian Xi
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab. Nature communications 15 (1) (2024)
Ruixi Wang, Shiliang Liu, Baoqing Chen, Qiaoqiao Li, Xingyuan Cheng, Yujia Zhu, Li Zhang, Yonghong Hu, Mengzhong Liu, Yingying Hu, Mian Xi
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study. British journal of cancer 131 (4) (2024)
Ruixi Wang, Shiliang Liu, Baoqing Chen, Qiaoqiao Li, Xingyuan Cheng, Yujia Zhu, Li Zhang, Yonghong Hu, Mengzhong Liu, Yingying Hu, Mian Xi
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study. British journal of cancer (2024)
Ruixi Wang, Shiliang Liu, Baoqing Chen, Qiaoqiao Li, Xingyuan Cheng, Yujia Zhu, Li Zhang, Yonghong Hu, Mengzhong Liu, Yingying Hu, Mian Xi
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study. British journal of cancer 131 (4) (2024)
Ruixi Wang, Shiliang Liu, Baoqing Chen, Qiaoqiao Li, Xingyuan Cheng, Yujia Zhu, Li Zhang, Yonghong Hu, Mengzhong Liu, Yingying Hu, Mian Xi
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study. British journal of cancer 131 (4) (2024)
Shiliang Liu, Liling Luo, Lei Zhao, Yujia Zhu, Hui Liu, Qiaoqiao Li, Ling Cai, Yonghong Hu, Bo Qiu, Li Zhang, JingXian Shen, Yadi Yang, Mengzhong Liu, Mian Xi
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial. Nature communications 12 (1) (2021)